4-methyl-2-[2-(4-trifluoromethyl-phenyl)-ethyl]-oxazole-5-carboxylic acid ethyl ester | 933772-54-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-methyl-2-[2-(4-trifluoromethyl-phenyl)-ethyl]-oxazole-5-carboxylic acid ethyl ester
• 英文别名: ethyl 4-methyl-2-[2-[4-(trifluoromethyl)phenyl]ethyl]-1,3-oxazole-5-carboxylate
• CAS: 933772-54-4
• 化学式: C₁₆H₁₆F₃NO₃
• 分子量: 327.303
• InChiKey: WNZHAPSRODKIOM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  23
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  52.3
• 氢给体数：
  0
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  4-methyl-2-[2-(4-trifluoromethyl-phenyl)-ethyl]-oxazole-5-carboxylic acid ethyl ester 在 lithium aluminium tetrahydride 、 水 、 氯化铵 作用下， 以 四氢呋喃 、 乙酸乙酯 为溶剂， 反应 1.0h， 生成 {4-methyl-2-[2-(4-trifluoromethyl-phenyl)-ethyl]-oxazol-5-yl}-methanol
  参考文献：
  名称：

  WO2007/39172

  摘要：

  公开号：
• 作为产物：
  描述：

  3-[4-(trifluoromethyl)phenyl]propionamide 、 2-氯乙酰乙酸乙酯 在 2-氯乙酰乙酸乙酯 、 silica gel 、 petroleum benzene 、 乙酸乙酯 作用下， 反应 8.0h， 以ethyl acetate=3:1 to obtain 13.75 g 4-methyl-2-[2-(4-trifluoromethyl-phenyl)-ethyl]-oxazole-5-carboxylic acid ethyl ester as an oil的产率得到4-methyl-2-[2-(4-trifluoromethyl-phenyl)-ethyl]-oxazole-5-carboxylic acid ethyl ester
  参考文献：
  名称：

  PHENYL-1,2,4-OXADIAZOLONE DERIVATIVES WITH PHENYL GROUP, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS

  摘要：

  本发明涉及具有苯基的苯基-1,2,4-噁二唑酮衍生物及其生理上可接受的盐和生理上功能衍生物，显示PPARδ激动剂活性。所描述的是式I的化合物，其中基团如定义所述，以及它们的生理上可接受的盐和它们的制备方法。这些化合物适用于治疗和/或预防脂肪酸代谢障碍和葡萄糖利用障碍以及胰岛素抵抗涉及的障碍以及中枢和外周神经系统的脱髓鞘和其他神经退行性疾病。

  公开号：

  US20090281084A1

文献信息

• PHENYL-1,2,4-OXADIAZOLONE DERIVATIVES WITH PHENYL GROUP, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS
  申请人：Bernardelli Patrick

  公开号：US20090281084A1

  公开（公告）日：2009-11-12

  The invention relates to phenyl-1,2,4-oxadiazolone derivatives with phenyl group and to their physiologically acceptable salts and physiologically functional derivatives showing PPARdelta agonist activity. What are described are compounds of the formula I, in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparations. The compounds are suitable for the treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization disorders as well as of disorders in which insulin resistance is involved and demyelinating and other neurodegenerative disorders of the central and peripheral nervous system.

  本发明涉及具有苯基的苯基-1,2,4-噁二唑酮衍生物及其生理上可接受的盐和生理上功能衍生物，显示PPARδ激动剂活性。所描述的是式I的化合物，其中基团如定义所述，以及它们的生理上可接受的盐和它们的制备方法。这些化合物适用于治疗和/或预防脂肪酸代谢障碍和葡萄糖利用障碍以及胰岛素抵抗涉及的障碍以及中枢和外周神经系统的脱髓鞘和其他神经退行性疾病。
• PHENYL AND PYRIDINYL-1,2,4-OXADIAZOLONE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS
  申请人：Bernardelli Patrick

  公开号：US20080287409A1

  公开（公告）日：2008-11-20

  The present invention comprises phenyl and pyridinyl 1,2,4-oxadiazolone compounds their physiologically acceptable salts and physiologically functional derivatives that exhibit peroxisome proliferator activator receptor (PPAR) delta agonist activity. Also described and claimed are processes for their preparation and their use as pharmaceuticals. These are compounds of formula I, in which the R-group substituents are defined herein. The compounds are suitable for the treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization disorders as well as of disorders in which insulin resistance is involved and de-myelinating and other neurodegenerative disorders of the central and peripheral nervous system.

  本发明涉及苯基和吡啶基1,2,4-噁二唑酮化合物及其生理上可接受的盐和生理功能衍生物，其表现出过氧化物酶体增殖物激活受体（PPAR）δ激动剂活性。还描述和声明了它们的制备过程以及它们作为药物的用途。这些化合物的化学式为I，其中R基取代基在此定义。这些化合物适用于治疗和/或预防脂肪酸代谢障碍和葡萄糖利用障碍以及胰岛素抵抗涉及的疾病，以及中枢和外周神经系统的去髓鞘和其他神经退行性疾病。
• PHENYL- AND PYRIDYL-I, 2 , 4 -OXADIAZOLONE DERIVATIVES WITH PHENYL GROUP, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS
  申请人：SANOFI

  公开号：EP1934206B1

  公开（公告）日：2011-12-14
• US7851493B2
  申请人：——

  公开号：US7851493B2

  公开（公告）日：2010-12-14
• [EN] PHENYL- AND PYRIDYL-I, 2 , 4 -OXADIAZOLONE DERIVATIVES WITH PHENYL GROUP, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS<br/>[FR] DERIVE DE PHENYL-1,2,4-OXADIAZOLONE COMPORTANT UN GROUPE PHENYL, PROCEDE SERVANT A LES PREPARER ET LEUR UTILISATION EN TANT QU'AGENTS PHARMACEUTIQUES
  申请人：SANOFI AVENTIS DEUTSCHLAND

  公开号：WO2007039172A1

  公开（公告）日：2007-04-12

  [EN] The invention relates to phenyl-1,2,4-oxadiazolone derivatives with phenyl group and to their physiologically acceptable salts and physiologically functional derivatives showing PPARdelta agonist activity. What is described are compounds of the formula (I) in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparations. The compounds are suitable for the treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization disorders as well as of disorders in which insulin resistance is involved and demyelinating and other neurodegenerative disorders of the central and peripheral nervous system.
  [FR] L'invention concerne des dérivés de phényl-1,2,4-oxadiazolone comportant un groupe phényl, et leurs sels acceptables sur le plan physiologique, ainsi que leurs dérivés fonctionnels sur le plan physiologique démontrant une activité d'agonistes de PPARdelta. Elle concerne des composés représentés par la formule (I) dans laquelle les radicaux sont tels qu'ils sont définis dans les revendications, leurs sels acceptables sur le plan physiologique et des procédés servant à les préparer. Ces composés sont adaptés pour traiter et/ou prévenir des troubles du métabolisme des acides gras et des troubles de l'utilisation du glucose et, également, des troubles dans lesquels la résistance à l'insuline joue un rôle, la démyélination ou d'autres maladies neurodégénératives du système nerveux central et périphérique.